Allspring Global Investments’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20,227
Closed -$1.06M 1714
2025
Q1
$1.06M Sell
20,227
-1,532
-7% -$86.1K ﹤0.01% 1238
2024
Q4
$1.2M Buy
21,759
+1,637
+8% +$86.1K ﹤0.01% 1255
2024
Q3
$1.01M Buy
20,122
+2,538
+14% +$117K ﹤0.01% 1330
2024
Q2
$773K Buy
17,584
+1,570
+10% +$66.8K ﹤0.01% 1397
2024
Q1
$704K Sell
16,014
-232
-1% -$10.3K ﹤0.01% 1447
2023
Q4
$771K Buy
16,246
+4,599
+39% +$193K ﹤0.01% 1401
2023
Q3
$517K Sell
11,647
-6,081
-34% -$283K ﹤0.01% 1519
2023
Q2
$846K Buy
17,728
+16,967
+2,230% +$765K ﹤0.01% 1457
2023
Q1
$29.9K Sell
761
-1,746
-70% -$63.5K ﹤0.01% 2429
2022
Q4
$70.9K Sell
2,507
-60,118
-96% -$1.72M ﹤0.01% 2211
2022
Q3
$1.88M Sell
62,625
-2,948
-4% -$103K ﹤0.01% 1248
2022
Q2
$2.23M Buy
65,573
+9,255
+16% +$332K ﹤0.01% 1193
2022
Q1
$2.52M Buy
56,318
+37,016
+192% +$1.71M ﹤0.01% 1386
2021
Q4
$891K Buy
+19,302
New +$779K ﹤0.01% 2011

Other funds holding IRMD

Allspring Global Investments's IRMD Position: Q2 2025 in Review

Allspring Global Investments sold out of iRadimed (IRMD) in Q2 2025, closing a stake of 20,227 shares — an estimated $1.06M sold.

Allspring Global Investments first reported a position in IRMD in Q4 2021 and held it in 14 quarters. The position peaked at $2.52M in Q1 2022. 162 funds tracked by Wall St. Rank hold IRMD as of Q2 2025.

  • Allspring Global Investments reported no remaining iRadimed position as of Q2 2025 after selling out during the quarter.
  • Allspring Global Investments sold 20,227 iRadimed shares in Q2 2025, an estimated $1.06M.
  • Allspring Global Investments first reported a position in iRadimed in Q4 2021 and held it in 14 quarters.
  • Allspring Global Investments's iRadimed position peaked at $2.52M in Q1 2022.
  • 162 funds tracked by Wall St. Rank held iRadimed as of Q2 2025.

Based on Allspring Global Investments's 13F filing for Q2 2025, filed 25 Jul 2025.